Ipso Ventures Share Discussion Threads

[falia] 15/9/2011 15:45

giving you 3.225 for your stock lolol

[electrick] 15/9/2011 15:45

certainly feels like a pump and dump

[falia] 15/9/2011 15:44

but for how long

[falia] 15/9/2011 15:43

mms letting you buy again

[falia] 15/9/2011 15:40

must be bored with their stocks

[falia] 15/9/2011 15:37

will in papers in the morning which will bring a lot more buyers

[moreforus] 15/9/2011 15:36

i see all the "characters" are coming out of the closet with a view on IPS....

[electrick] 15/9/2011 15:36

Given this was approved on 5th Sept and there were no movements in the share price following licencing I am sceptical as to why the rise now... especially with all the spamming other boards....

I can find no indication as to the level of royalties to Therakind or the level of the payment it would be due or the timesccales as to when payment would be made...

I also am not fgamiliar with a PUMA - the note above states "PUMAs are designed to encourage the development of older medicines, which are no longer covered by a patent"... not covered by a patent??

Hmmn

[tez123] 15/9/2011 15:31

Buccolam now licensed for children in an EU first

Fri, 09/09/2011 - 14:04
By News team
Buccolam, an oromucosal solution of midazolam, is now licensed for children aged between three months and 18 years of age for the treatment of severe convulsions and epileptic seizures, after becoming the first medicine to be granted a paediatric-use marketing authorisation (PUMA).

The licence was granted by the European Commission on 5 September 2011 and the product, from ViroPharma SPRL, is expected to be available in the UK from early October 2011.

June Raine, director of vigilance and risk management of medicines at the Medicines and Healthcare products Regulatory Agency, welcomed the news. She said: "We hope . . . the introduction of the first PUMA will lead to many more children's only medicines being made available in the UK."
PUMAs are designed to encourage the development of older medicines, which are no longer covered by a patent, for use in children.
See also: Medicines tailored for children - the introduction of buccal midazolam

[falia] 15/9/2011 15:30

excellent news should easily see 5p

[hyper al] 15/9/2011 15:29

If you lot from LDP are looking for a biotech you should be looking at SUMM if you want to get in before any rise. Worth a look.

[tomboyb] 15/9/2011 15:28

cpurser2 - 15 Sep'11 - 15:18 - 181 of 184


Tomboy got any 3 month targets on these and a quick run down on why its worth a punt at this level. thanks mate

I do have a target and i will explain later - Now its a question how cheap can you get it considering the overhand imo has potentially cleared.

WINS on the BID now - 2 v 1 ---

[tomboyb] 15/9/2011 15:23

EU grants approval for Buccolam
15 September 2011 | 14:36pm
StockMarketWire.com - Buccolam - a product developed by IPSO Ventures' portfolio company Therakind - has been granted European Commission approval for the treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents from three months to less than 18 years. This approval has triggered a further milestone payment for Therakind.

Therakind is expected to also receive royalties on sales of this product as Viropharma is now able to actively market this product across Europe.

IPSO has a 36% shareholding in Therakind.

[falia] 15/9/2011 15:21

should see 4p by close

[falia] 15/9/2011 15:19

mms widen the spread

[falia] 15/9/2011 15:17

thanks a lot info

[comedy] 15/9/2011 15:16

took another 50k.

[falia] 15/9/2011 15:15

mms lololol oh dear me

[falia] 15/9/2011 15:11

mms will try everything today to get your stock lololo